tradingkey.logo

Venus Concept Inc

VERO
1.760USD
-0.020-1.12%
Close 12/24, 13:00ETQuotes delayed by 15 min
3.27MMarket Cap
LossP/E TTM

Venus Concept Inc

1.760
-0.020-1.12%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of Venus Concept Inc

Currency: USD Updated: 2025-12-24

Key Insights

Venus Concept Inc's fundamentals are relatively stable, and its growth potential is significant.Its valuation is considered fairly valued, ranking 138/206 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 0.00.In the medium term, the stock price is expected to trend down.The company has shown weak stock market performance over the past month, in line with its weak fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Venus Concept Inc's Score

Industry at a Glance

Industry Ranking
138 / 206
Overall Ranking
357 / 4562
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Analyst Rating

Based on 2 analysts
Hold
Current Rating
0.000
Target Price
0.00%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Venus Concept Inc Highlights

StrengthsRisks
Venus Concept Inc. is a global medical technology company. The Company develops, commercializes and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services and reaches over 60 countries and nine direct markets. The Company’s product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Versa Pro, Venus Legacy, Venus Velocity, Venus Viva, Venus Glow, Venus Bliss, Venus Bliss MAX, Venus Epileve, Venus Viva MD and AI.ME. Its treatments for hair loss are divided into non-surgical options and surgical procedures. Its hair restoration systems include NeoGraft and the ARTAS iX Robotic Hair Restoration system. Its systems are designed on flexible platforms that enable it to expand beyond the aesthetic industry’s traditional markets of dermatology and plastic surgery, and into non-traditional markets, including family medicine and general practitioners and aesthetic medical spas.
Growing
The company is in a growing phase, with the latest annual income totaling USD 64.83M.
Overvalued
The company’s latest PE is -0.04, at a high 3-year percentile range.
Institutional Buying
The latest institutional holdings are 256.25K shares, increasing 19.61% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 2.03K shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.97.

Financial Health

Currency: USD Updated: 2025-12-24

The current financial score of Venus Concept Inc is 5.95, ranking 183/206 in the Healthcare Equipment & Supplies industry. Its financial status is weak, and its operating efficiency is average. Its latest quarterly revenue reached 13.78M, representing a year-over-year decrease of 8.20%, while its net profit experienced a year-over-year decrease of 143.00%.

Score

Industry at a Glance

Previous score
5.95
Change
0

Financials

4.28

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.

Quality of Earnings

6.63

Operational Efficiency

6.01

Growth Potential

5.75

Shareholder Returns

7.07

Venus Concept Inc's Company Valuation

Currency: USD Updated: 2025-12-24

The current valuation score of Venus Concept Inc is 7.60, ranking 74/206 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -0.04, which is -46.45% below the recent high of -0.02 and -14451.72% above the recent low of -6.36.

Score

Industry at a Glance

Previous score
7.60
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 138/206
Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2025-12-24

The current earnings forecast score of Venus Concept Inc is 6.00, ranking 174/206 in the Healthcare Equipment & Supplies industry.

Score

Industry at a Glance

Previous score
6.00
Change
0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 2 analysts
Hold
Current Rating
0.000
Target Price
0.00%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

90
Total
4
Median
7
Average
Company name
Ratings
Analysts
Venus Concept Inc
VERO
2
Boston Scientific Corp
BSX
36
Veeva Systems Inc
VEEV
34
Intuitive Surgical Inc
ISRG
34
Edwards Lifesciences Corp
EW
34
Thermo Fisher Scientific Inc
TMO
27
1
2
3
...
18

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-12-24

The current price momentum score of Venus Concept Inc is 4.40, ranking 189/206 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 2.54 and the support level at 1.31, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
4.68
Change
-0.28

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(3)
Neutral(1)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-0.005
Sell
RSI(14)
44.842
Neutral
STOCH(KDJ)(9,3,3)
13.121
Oversold
ATR(14)
0.250
High Vlolatility
CCI(14)
-134.017
Sell
Williams %R
89.431
Oversold
TRIX(12,20)
-0.137
Sell
StochRSI(14)
0.000
Oversold
Moving Average
Sell(6)
Neutral(0)
Buy(0)
Indicators
Value
Direction
MA5
1.844
Sell
MA10
1.868
Sell
MA20
1.881
Sell
MA50
1.983
Sell
MA100
2.172
Sell
MA200
2.429
Sell

Institutional Confidence

Currency: USD Updated: 2025-12-24

The current institutional shareholding score of Venus Concept Inc is 3.00, ranking 135/206 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 13.78%, representing a quarter-over-quarter decrease of 15.55%. The largest institutional shareholder is The Vanguard, holding a total of 2.03K shares, representing 0.11% of shares outstanding, with 1.00% increase in holdings.

Score

Industry at a Glance

Previous score
3.00
Change
0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name
Shares Held
Chg %
Orca Capital GmbH
101.75K
--
EW Healthcare Partners
99.02K
+0.00%
HealthQuest Capital Management, L.P
41.19K
--
Madryn Asset Management, LP
10.19K
--
De Silva (Rajiv)
7.58K
--
Tower Research Capital LLC
3.92K
+120.03%
1
2

Risk Assessment

Currency: USD Updated: 2025-12-24

The current risk assessment score of Venus Concept Inc is 2.21, ranking 167/206 in the Healthcare Equipment & Supplies industry. The company's beta value is -0.06. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.

Score

Industry at a Glance

Previous score
2.21
Change
0
Beta vs S&P 500 index
-0.06
VaR
+10.00%
240-Day Maximum Drawdown
+81.30%
240-Day Volatility
+215.56%

Return

Best Daily Return
60 days
+35.33%
120 days
+35.33%
5 years
+205.76%
Worst Daily Return
60 days
-19.47%
120 days
-19.47%
5 years
-54.55%
Sharpe Ratio
60 days
-0.48
120 days
-0.52
5 years
-0.10

Risk Assessment

Maximum Drawdown
240 days
+81.30%
3 years
+96.51%
5 years
+99.69%
Return-to-Drawdown Ratio
240 days
-0.72
3 years
-0.33
5 years
-0.20
Skewness
240 days
+8.95
3 years
+8.29
5 years
+8.38

Volatility

Realised Volatility
240 days
+215.56%
5 years
+172.06%
Standardised True Range
240 days
+19.32%
5 years
+455.38%
Downside Risk-Adjusted Return
120 days
-83.86%
240 days
-83.86%
Maximum Daily Upside Volatility
60 days
+189.18%
Maximum Daily Downside Volatility
60 days
+86.51%

Liquidity

Average Turnover Rate
60 days
+221.12%
120 days
+218.14%
5 years
--
Turnover Deviation
20 days
-96.66%
60 days
+26.20%
120 days
+24.50%

Peer Comparison

Healthcare Equipment & Supplies
Venus Concept Inc
Venus Concept Inc
VERO
5.23 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Edwards Lifesciences Corp
Edwards Lifesciences Corp
EW
8.69 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Artivion Inc
Artivion Inc
AORT
8.54 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Lantheus Holdings Inc
Lantheus Holdings Inc
LNTH
8.48 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Tactile Systems Technology Inc
Tactile Systems Technology Inc
TCMD
8.46 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
AxoGen Inc
AxoGen Inc
AXGN
8.39 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more

FAQs

How does TradingKey generate the Stock Score of Venus Concept Inc?

The TradingKey Stock Score provides a comprehensive assessment of Venus Concept Inc based on 34 indicators derived from over 100 underlying data points.
These indicators are categorised into six key dimensions: financial health, company profile, earnings forecasts, price momentum, institutional confidence, and risk assessment, collectively providing investors with a thorough analysis of Venus Concept Inc’s performance and outlook.

How do we generate the financial health score of Venus Concept Inc?

To generate the financial health score of Venus Concept Inc, we analyse various key financial indicators across several core dimensions, including financial fundamentals, earnings quality, operational efficiency, growth potential, and shareholder returns.
By integrating these comprehensive data, the financial health score not only reflects Venus Concept Inc's overall stability, operational efficiency, and growth potential but also captures the investment returns delivered to shareholders. This score aims to support rational decision-making for investors and other stakeholders. A higher score indicates a better financial health of Venus Concept Inc.

How do we generate the company valuation score of Venus Concept Inc?

To generate the company valuation score of Venus Concept Inc, we use several key financial ratios, including P/E, P/B, P/S, and P/CF. These metrics compare Venus Concept Inc’s market value to its earnings, assets, sales, and cash flow, serving as core indicators for assessing company value.
By analysing these ratios in an all-round manner, the valuation score reflects not only the market’s current perception of Venus Concept Inc’s value but also its future profitability and growth potential, thereby supporting more informed investment decisions. A higher score indicates a fairer valuation of Venus Concept Inc.

How do we generate the earnings forecast score of Venus Concept Inc?

To calculate the earnings forecast score of Venus Concept Inc, we consider various key indicators such as analyst ratings, financial forecasts, support and resistance levels, and peer comparisons:
Current ratings and price targets directly reflect analysts’ expectations, while the upside space indicates their views on the stock’s growth potential.
Financial metrics like earnings per share (EPS), revenue, net income, and earnings before interest and taxes (EBIT) are core measures for assessing profitability.
By analysing the high, median, and low ranges of the target price, we can identify price trends and determine key support and resistance levels.
Comparing these indicators against peers provides context for the stock’s performance and helps anchor more realistic expectations.
These factors together form a comprehensive earnings forecast score that accurately reflects the stock’s expected financial performance and growth potential. A higher score suggests that analysts have a more optimistic outlook on Venus Concept Inc’s future.

How do we generate the price momentum score of Venus Concept Inc?

When generating the price momentum score for Venus Concept Inc, we examine momentum indicators including support and resistance levels as well as volume metrics.
Support levels represent price points where buying interest is strong enough to prevent further declines, while resistance levels indicate prices where selling pressure may hinder upward movement. By analysing typical price volume alongside total volume, we assess overall market activity and liquidity. These indicators help identify price trends and potential shifts, enabling more accurate predictions of future earnings.
This comprehensive approach can reflect market sentiment and enable rational forecasts of Venus Concept Inc’s prices. A higher score indicates a more stable short-term price trend for Venus Concept Inc.

How do we generate the institutional confidence score of Venus Concept Inc?

To generate the institutional confidence score of Venus Concept Inc, we analyse both the proportion of shares held by institutions and the number of shares they own. A higher institutional ownership percentage indicates strong confidence of professional investors, which is generally a positive signal about Venus Concept Inc’s potential. By examining the number of shares held, we gain deeper insight into institutions’ commitment and attitude toward the stock, as institutional investors typically conduct thorough analysis before making investment decisions. Understanding institutional confidence helps us refine earnings forecasts and provides a more reliable perspective on the company’s future performance and market stability. A higher score indicates greater institutional endorsement of Venus Concept Inc.

How do we generate the risk management score of Venus Concept Inc?

To assess the risk management score of Venus Concept Inc, we examine multiple key indicators related to returns, risk, volatility, and liquidity.
The highest and lowest daily returns reflect the potential size of gains and losses, while the Sharpe ratio measures risk-adjusted return performance. On the risk side, we analyse maximum drawdown and the return-to-drawdown ratio to identify extreme loss scenarios. Skewness helps assess the distribution of returns and whether performance may be biased. Volatility indicators—such as realised volatility and standardised true range—reveal price fluctuations. Downside risk-adjusted returns provide insight into potential losses and gains. Lastly, liquidity metrics like average turnover rate and turnover deviation indicate how actively the stock is traded.
These indicators together provide a multi-dimensional understanding of Venus Concept Inc’s risk-return profile, serving as core factors of the risk management score. A higher score indicates lower risk on the side of Venus Concept Inc.
KeyAI